Between 2024 and 2028, the R&D budget for Health and Medical Sciences in France, expressed as a percentage of GDP, consistently decreases from 0.081% to 0.076%. This anticipated decline suggests a conservative or contracting investment trend by approximately 1% year-on-year from 2025 onwards.
Future trends to watch for include potential influences of governmental policy shifts, economic conditions impacting GDP allocations, and innovation demands necessitating increased financial inputs into the health sector. Stakeholders should also consider the implications of emerging health technologies and global health challenges that could reshape budget priorities.
